Analytical validation and evaluation of the effects of intramuscular injections on acute phase proteins in horses

Gordon, Danielle Louise

Permalink

https://hdl.handle.net/2142/108097 Copy

Description

Title

Analytical validation and evaluation of the effects of intramuscular injections on acute phase proteins in horses

Author(s)

Gordon, Danielle Louise

Issue Date

2020-03-30

Director of Research (if dissertation) or Advisor (if thesis)

Foreman, Jonathan H

Committee Member(s)

• Barger, Anne M
• Schnelle, Amy N
• Connolly, Sara L
• Fan, Timothy M

Department of Study

Vet Clinical Medicine

Discipline

VMS-Veterinary Clinical Medcne

Degree Granting Institution

University of Illinois at Urbana-Champaign

Degree Name

M.S.

Degree Level

Thesis

Keyword(s)

• Acute phase protein
• Acute phase response
• equine
• horse
• inflammation
• intramuscular injection
• method validation

Abstract

Acute phase protein (APP) measurement can be used to characterize and detect inflammation, as well as monitor response to therapy. Intramuscular (IM) injections often result in local swelling and inflammation, which may lead to increased plasma concentrations of APP. The first objective of this study was to determine whether equine plasma haptoglobin (HAP) concentrations could be measured reliably with an immunoturbidimetric assay developed for use in humans. Within run and between run imprecisions were evaluated by multiple measurements of equine plasma samples with high, intermediate, and low HAP concentrations. Assay inaccuracy was determined by linearity under dilution. In plasma samples with high, intermediate, and low HAP concentrations, the within run imprecisions were 3.13%, 1.89%, and 1.76%, and the between run imprecisions were 2.77%, 1.45%, and 1.21%. Acceptable linearity within a range of 7-122 mg/dL was observed. The detection limit was 0 mg/dL. No clinically significant interference was observed from hemoglobin, lipids, or bilirubin. In conclusion, equine HAP concentrations can be measured reliably up to 122 mg/dL using the immunoturbidimetric assay designed for human HAP. The second objective was to evaluate the possible effects of IM procaine penicillin G (PPG) injections on plasma concentrations of selected APP, including fibrinogen (FIB), serum amyloid A (SAA), and HAP, as well as on the activity of selected enzymes, including creatine kinase (CK) and aspartate aminotransferase (AST). The plasma concentrations of the aforementioned variables were evaluated for 5 consecutive days prior to drug administration (days -5 to -1), during a 5-day course of PPG administered twice daily at a recommended therapeutic dose (days 0 to 4), and for 20 days following the final injection (days 5 to 24). Results showed a significant increase in CK activity on days 1-6 and an increase in AST activity on days 2-7 and 10. A significant increase in plasma FIB was noted on days 6-8 and 10, and SAA on day 6. No significant changes in HAP were observed. These findings indicate that muscle injury caused by PPG injections may result in increased CK and AST activity and increased plasma concentration of a subset of APP including FIB and SAA.

Graduation Semester

2020-05

Type of Resource

Thesis

Permalink

http://hdl.handle.net/2142/108097

Copyright and License Information

Copyright 2020 Danielle Gordon

Owning Collections